ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.3X leverage
AstraZeneca Pharma India live price: ₹8704.5. It opened at ₹8,560 vs previous close ₹8,601; intraday high/low: ₹8,745/₹8,509. The 50 & 200 DMA stand at ₹8,761.11/₹8,671.30.
AstraZeneca Pharma India Performance
- Low
- ₹8,509
- High
- ₹8,745
- 52 Week Low
- ₹7,181
- 52 Week High
- ₹10,691
- Open Price₹8,560
- Previous Close₹8,601
- Volume3,424
- 50 DMA₹8,761.11
- 100 DMA₹8,806.53
- 200 DMA₹8,671.30
Investment Returns
- Over 1 Month + 0.96%
- Over 3 Month -5.66%
- Over 6 Month -4.24%
- Over 1 Year + 18.6%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 108.3
- PEG Ratio
- 1
- Market Cap Cr
- 21,761
- P/B Ratio
- 26.2
- Average True Range
- 211.66
- EPS
- 83.21
- Dividend Yield
- 0.4
- MACD Signal
- 45.94
- RSI
- 47.13
- MFI
- 34.15
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹8,704.50
+
103.5
(1.2%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹8,765.79
- 50 Day
- ₹8,761.11
- 100 Day
- ₹8,806.53
- 200 Day
- ₹8,671.30
Resistance and Support
8652.83
- R3 9,032.67
- R2 8,888.83
- R1 8,796.67
- S1 8,560.67
- S2 8,416.83
- S3 8,324.67
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹8,704 As on 06 March, 2026 | 20:26
The Market Cap of AstraZeneca Pharma India is ₹21761.2 Cr As on 06 March, 2026 | 20:26
The P/E ratio of AstraZeneca Pharma India is 108.3 As on 06 March, 2026 | 20:26
The PB ratio of AstraZeneca Pharma India is 26.2 As on 06 March, 2026 | 20:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.